BRAF and metastatic melanoma: Among metastatic melanomas, oncogenic BRAF mutations are found in over half of patients with a substitution of glutamic acid for valine at amino acid position 600 (V600E) of the BRAF kinase domain comprising the most common mutation, accounting for 70–88% of cases5,6.